GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (OTCPK:PHGUF) » Definitions » E10

PHGUF (Pharming Group) E10 : $-0.01 (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Pharming Group E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pharming Group's adjusted earnings per share data for the three months ended in Sep. 2024 was $-0.002. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.01 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was -4.70% per year. During the past 5 years, the average E10 Growth Rate was -1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Pharming Group was 6.80% per year. The lowest was -4.70% per year. And the median was -0.95% per year.

As of today (2024-12-13), Pharming Group's current stock price is $0.76325. Pharming Group's E10 for the quarter that ended in Sep. 2024 was $-0.01. Pharming Group's Shiller PE Ratio of today is .


Pharming Group E10 Historical Data

The historical data trend for Pharming Group's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group E10 Chart

Pharming Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.64 -5.98 -5.80 -5.95 -6.46

Pharming Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.11 -6.46 -0.01 -0.01 -0.01

Competitive Comparison of Pharming Group's E10

For the Biotechnology subindustry, Pharming Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharming Group's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharming Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pharming Group's Shiller PE Ratio falls into.



Pharming Group E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharming Group's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.002/131.6100*131.6100
=-0.002

Current CPI (Sep. 2024) = 131.6100.

Pharming Group Quarterly Data

per share eps CPI Adj_EPS
201412 0.040 99.050 0.053
201503 -0.003 99.750 -0.004
201506 -0.007 100.230 -0.009
201509 -0.007 100.500 -0.009
201512 -0.011 99.730 -0.015
201603 -0.009 100.310 -0.012
201606 -0.009 100.260 -0.012
201609 -0.010 100.570 -0.013
201612 -0.016 100.710 -0.021
201703 -0.013 101.440 -0.017
201706 -0.060 101.370 -0.078
201709 -0.020 102.030 -0.026
201712 -0.092 101.970 -0.119
201803 0.010 102.470 0.013
201806 0.005 103.100 0.006
201809 0.009 103.950 0.011
201812 0.019 103.970 0.024
201903 0.011 105.370 0.014
201906 0.012 105.840 0.015
201909 0.017 106.700 0.021
201912 0.022 106.800 0.027
202003 0.012 106.850 0.015
202006 0.016 107.510 0.020
202009 0.013 107.880 0.016
202012 0.011 107.850 0.013
202103 0.013 108.870 0.016
202106 0.006 109.670 0.007
202109 -0.001 110.790 -0.001
202112 0.003 114.010 0.003
202203 0.005 119.460 0.006
202206 0.022 119.050 0.024
202209 0.013 126.890 0.013
202212 -0.022 124.940 -0.023
202303 -0.019 124.720 -0.020
202306 0.002 125.830 0.002
202309 0.005 127.160 0.005
202312 -0.005 126.450 -0.005
202403 -0.019 128.580 -0.019
202406 -0.001 129.910 -0.001
202409 -0.002 131.610 -0.002

Add all the adjusted EPS together and divide 10 will get our e10.


Pharming Group  (OTCPK:PHGUF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pharming Group E10 Related Terms

Thank you for viewing the detailed overview of Pharming Group's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharming Group Business Description

Traded in Other Exchanges
Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

Pharming Group Headlines

From GuruFocus

Q4 2023 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 03-15-2024

Q3 2021 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Pharming Group NV Annual Shareholders Meeting Transcript

By GuruFocus Research 02-08-2024

Q1 2023 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Pharming Group NV Annual Shareholders Meeting Transcript

By GuruFocus Research 02-08-2024

Q2 2022 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q2 2024 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 08-02-2024

Q4 2020 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024

Q1 2022 Pharming Group NV Earnings Call Transcript

By GuruFocus Research 02-08-2024